The global Nonalcoholic Steatohepatitis Diagnostic market size was estimated at USD 1423.50 million in 2024 and is projected to reach USD 2265.75 million by 2032, exhibiting a CAGR of 5.30% during the forecast period.
North America Nonalcoholic Steatohepatitis Diagnostic market size was estimated at USD 405.39 million in 2024, at a CAGR of 4.54% during the forecast period of 2025 through 2032.
Report Overview
Nonalcoholic steatohepatitis (NASH) is liver inflammation and damage caused by a buildup of fat in the liver. It is part of a group of conditions called nonalcoholic fatty liver disease.
This report provides a deep insight into the global Nonalcoholic Steatohepatitis Diagnostic market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Nonalcoholic Steatohepatitis Diagnostic Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Nonalcoholic Steatohepatitis Diagnostic market in any manner.
Global Nonalcoholic Steatohepatitis Diagnostic Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
- Echosens
- Prometheus Laboratories
- GENFIT SA
- Siemens Medical Solutions USA
- Inc.
- BioPredictive S.A.S
- Quest Diagnostics Incorporated.
- Meridian Bioscience
- Inc.
- Laboratory Corporation of America Holdings
Market Segmentation (by Type)
- Serum Biomarkers
- Hepatic Fibrosis Biomarkers
- Oxidative Stress Biomarkers
- Apoptosis Biomarkers
- Others
Market Segmentation (by Application)
- Pharma & CRO Industry
- Hospitals
- Academic Research Institutes
- Others
Geographic Segmentation
- North America (USA, Canada, Mexico)
- Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
- Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
- South America (Brazil, Argentina, Columbia, Rest of South America)
- The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
Key Benefits of This Market Research:
- Industry drivers, restraints, and opportunities covered in the study
- Neutral perspective on the market performance
- Recent industry trends and developments
- Competitive landscape & strategies of key players
- Potential & niche segments and regions exhibiting promising growth covered
- Historical, current, and projected market size, in terms of value
- In-depth analysis of the Nonalcoholic Steatohepatitis Diagnostic Market
- Overview of the regional outlook of the Nonalcoholic Steatohepatitis Diagnostic Market:
Key Reasons to Buy this Report:
- Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
- This enables you to anticipate market changes to remain ahead of your competitors
- You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
- The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
- Provision of market value data for each segment and sub-segment
- Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
- Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
- Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
- Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
- The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
- Includes in-depth analysis of the market from various perspectives through Porter
TABLE OF CONTENTS
Table of Contents
1 Research Methodology and Statistical Scope
1.1 Market Definition and Statistical Scope of Nonalcoholic Steatohepatitis Diagnostic
1.2 Key Market Segments
1.2.1 Nonalcoholic Steatohepatitis Diagnostic Segment by Type
1.2.2 Nonalcoholic Steatohepatitis Diagnostic Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 Nonalcoholic Steatohepatitis Diagnostic Market Overview
2.1 Global Market Overview
2.1.1 Global Nonalcoholic Steatohepatitis Diagnostic Market Size (M USD) Estimates and Forecasts (2019-2032)
2.1.2 Global Nonalcoholic Steatohepatitis Diagnostic Sales Estimates and Forecasts (2019-2032)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 Nonalcoholic Steatohepatitis Diagnostic Market Competitive Landscape
3.1 Global Nonalcoholic Steatohepatitis Diagnostic Sales by Manufacturers (2019-2025)
3.2 Global Nonalcoholic Steatohepatitis Diagnostic Revenue Market Share by Manufacturers (2019-2025)
3.3 Nonalcoholic Steatohepatitis Diagnostic Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Nonalcoholic Steatohepatitis Diagnostic Average Price by Manufacturers (2019-2025)
3.5 Manufacturers Nonalcoholic Steatohepatitis Diagnostic Sales Sites, Area Served, Product Type
3.6 Nonalcoholic Steatohepatitis Diagnostic Market Competitive Situation and Trends
3.6.1 Nonalcoholic Steatohepatitis Diagnostic Market Concentration Rate
3.6.2 Global 5 and 10 Largest Nonalcoholic Steatohepatitis Diagnostic Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 Nonalcoholic Steatohepatitis Diagnostic Industry Chain Analysis
4.1 Nonalcoholic Steatohepatitis Diagnostic Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 The Development and Dynamics of Nonalcoholic Steatohepatitis Diagnostic Market
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 Nonalcoholic Steatohepatitis Diagnostic Market Segmentation by Type
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Nonalcoholic Steatohepatitis Diagnostic Sales Market Share by Type (2019-2025)
6.3 Global Nonalcoholic Steatohepatitis Diagnostic Market Size Market Share by Type (2019-2025)
6.4 Global Nonalcoholic Steatohepatitis Diagnostic Price by Type (2019-2025)
7 Nonalcoholic Steatohepatitis Diagnostic Market Segmentation by Application
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Nonalcoholic Steatohepatitis Diagnostic Market Sales by Application (2019-2025)
7.3 Global Nonalcoholic Steatohepatitis Diagnostic Market Size (M USD) by Application (2019-2025)
7.4 Global Nonalcoholic Steatohepatitis Diagnostic Sales Growth Rate by Application (2019-2025)
8 Nonalcoholic Steatohepatitis Diagnostic Market Consumption by Region
8.1 Global Nonalcoholic Steatohepatitis Diagnostic Sales by Region
8.1.1 Global Nonalcoholic Steatohepatitis Diagnostic Sales by Region
8.1.2 Global Nonalcoholic Steatohepatitis Diagnostic Sales Market Share by Region
8.2 North America
8.2.1 North America Nonalcoholic Steatohepatitis Diagnostic Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Nonalcoholic Steatohepatitis Diagnostic Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Nonalcoholic Steatohepatitis Diagnostic Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Nonalcoholic Steatohepatitis Diagnostic Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Nonalcoholic Steatohepatitis Diagnostic Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 Nonalcoholic Steatohepatitis Diagnostic Market Production by Region
9.1 Global Production of Nonalcoholic Steatohepatitis Diagnostic by Region (2019-2025)
9.2 Global Nonalcoholic Steatohepatitis Diagnostic Revenue Market Share by Region (2019-2025)
9.3 Global Nonalcoholic Steatohepatitis Diagnostic Production, Revenue, Price and Gross Margin (2019-2025)
9.4 North America Nonalcoholic Steatohepatitis Diagnostic Production
9.4.1 North America Nonalcoholic Steatohepatitis Diagnostic Production Growth Rate (2019-2025)
9.4.2 North America Nonalcoholic Steatohepatitis Diagnostic Production, Revenue, Price and Gross Margin (2019-2025)
9.5 Europe Nonalcoholic Steatohepatitis Diagnostic Production
9.5.1 Europe Nonalcoholic Steatohepatitis Diagnostic Production Growth Rate (2019-2025)
9.5.2 Europe Nonalcoholic Steatohepatitis Diagnostic Production, Revenue, Price and Gross Margin (2019-2025)
9.6 Japan Nonalcoholic Steatohepatitis Diagnostic Production (2019-2025)
9.6.1 Japan Nonalcoholic Steatohepatitis Diagnostic Production Growth Rate (2019-2025)
9.6.2 Japan Nonalcoholic Steatohepatitis Diagnostic Production, Revenue, Price and Gross Margin (2019-2025)
9.7 China Nonalcoholic Steatohepatitis Diagnostic Production (2019-2025)
9.7.1 China Nonalcoholic Steatohepatitis Diagnostic Production Growth Rate (2019-2025)
9.7.2 China Nonalcoholic Steatohepatitis Diagnostic Production, Revenue, Price and Gross Margin (2019-2025)
10 Key Companies Profile
10.1 Echosens
10.1.1 Echosens Nonalcoholic Steatohepatitis Diagnostic Basic Information
10.1.2 Echosens Nonalcoholic Steatohepatitis Diagnostic Product Overview
10.1.3 Echosens Nonalcoholic Steatohepatitis Diagnostic Product Market Performance
10.1.4 Echosens Business Overview
10.1.5 Echosens Nonalcoholic Steatohepatitis Diagnostic SWOT Analysis
10.1.6 Echosens Recent Developments
10.2 Prometheus Laboratories
10.2.1 Prometheus Laboratories Nonalcoholic Steatohepatitis Diagnostic Basic Information
10.2.2 Prometheus Laboratories Nonalcoholic Steatohepatitis Diagnostic Product Overview
10.2.3 Prometheus Laboratories Nonalcoholic Steatohepatitis Diagnostic Product Market Performance
10.2.4 Prometheus Laboratories Business Overview
10.2.5 Prometheus Laboratories Nonalcoholic Steatohepatitis Diagnostic SWOT Analysis
10.2.6 Prometheus Laboratories Recent Developments
10.3 GENFIT SA
10.3.1 GENFIT SA Nonalcoholic Steatohepatitis Diagnostic Basic Information
10.3.2 GENFIT SA Nonalcoholic Steatohepatitis Diagnostic Product Overview
10.3.3 GENFIT SA Nonalcoholic Steatohepatitis Diagnostic Product Market Performance
10.3.4 GENFIT SA Nonalcoholic Steatohepatitis Diagnostic SWOT Analysis
10.3.5 GENFIT SA Business Overview
10.3.6 GENFIT SA Recent Developments
10.4 Siemens Medical Solutions USA
10.4.1 Siemens Medical Solutions USA Nonalcoholic Steatohepatitis Diagnostic Basic Information
10.4.2 Siemens Medical Solutions USA Nonalcoholic Steatohepatitis Diagnostic Product Overview
10.4.3 Siemens Medical Solutions USA Nonalcoholic Steatohepatitis Diagnostic Product Market Performance
10.4.4 Siemens Medical Solutions USA Business Overview
10.4.5 Siemens Medical Solutions USA Recent Developments
10.5 Inc.
10.5.1 Inc. Nonalcoholic Steatohepatitis Diagnostic Basic Information
10.5.2 Inc. Nonalcoholic Steatohepatitis Diagnostic Product Overview
10.5.3 Inc. Nonalcoholic Steatohepatitis Diagnostic Product Market Performance
10.5.4 Inc. Business Overview
10.5.5 Inc. Recent Developments
10.6 BioPredictive S.A.S
10.6.1 BioPredictive S.A.S Nonalcoholic Steatohepatitis Diagnostic Basic Information
10.6.2 BioPredictive S.A.S Nonalcoholic Steatohepatitis Diagnostic Product Overview
10.6.3 BioPredictive S.A.S Nonalcoholic Steatohepatitis Diagnostic Product Market Performance
10.6.4 BioPredictive S.A.S Business Overview
10.6.5 BioPredictive S.A.S Recent Developments
10.7 Quest Diagnostics Incorporated.
10.7.1 Quest Diagnostics Incorporated. Nonalcoholic Steatohepatitis Diagnostic Basic Information
10.7.2 Quest Diagnostics Incorporated. Nonalcoholic Steatohepatitis Diagnostic Product Overview
10.7.3 Quest Diagnostics Incorporated. Nonalcoholic Steatohepatitis Diagnostic Product Market Performance
10.7.4 Quest Diagnostics Incorporated. Business Overview
10.7.5 Quest Diagnostics Incorporated. Recent Developments
10.8 Meridian Bioscience
10.8.1 Meridian Bioscience Nonalcoholic Steatohepatitis Diagnostic Basic Information
10.8.2 Meridian Bioscience Nonalcoholic Steatohepatitis Diagnostic Product Overview
10.8.3 Meridian Bioscience Nonalcoholic Steatohepatitis Diagnostic Product Market Performance
10.8.4 Meridian Bioscience Business Overview
10.8.5 Meridian Bioscience Recent Developments
10.9 Inc.
10.9.1 Inc. Nonalcoholic Steatohepatitis Diagnostic Basic Information
10.9.2 Inc. Nonalcoholic Steatohepatitis Diagnostic Product Overview
10.9.3 Inc. Nonalcoholic Steatohepatitis Diagnostic Product Market Performance
10.9.4 Inc. Business Overview
10.9.5 Inc. Recent Developments
10.10 Laboratory Corporation of America Holdings
10.10.1 Laboratory Corporation of America Holdings Nonalcoholic Steatohepatitis Diagnostic Basic Information
10.10.2 Laboratory Corporation of America Holdings Nonalcoholic Steatohepatitis Diagnostic Product Overview
10.10.3 Laboratory Corporation of America Holdings Nonalcoholic Steatohepatitis Diagnostic Product Market Performance
10.10.4 Laboratory Corporation of America Holdings Business Overview
10.10.5 Laboratory Corporation of America Holdings Recent Developments
11 Nonalcoholic Steatohepatitis Diagnostic Market Forecast by Region
11.1 Global Nonalcoholic Steatohepatitis Diagnostic Market Size Forecast
11.2 Global Nonalcoholic Steatohepatitis Diagnostic Market Forecast by Region
11.2.1 North America Market Size Forecast by Country
11.2.2 Europe Nonalcoholic Steatohepatitis Diagnostic Market Size Forecast by Country
11.2.3 Asia Pacific Nonalcoholic Steatohepatitis Diagnostic Market Size Forecast by Region
11.2.4 South America Nonalcoholic Steatohepatitis Diagnostic Market Size Forecast by Country
11.2.5 Middle East and Africa Forecasted Consumption of Nonalcoholic Steatohepatitis Diagnostic by Country
12 Forecast Market by Type and by Application (2025-2032)
12.1 Global Nonalcoholic Steatohepatitis Diagnostic Market Forecast by Type (2025-2032)
12.1.1 Global Forecasted Sales of Nonalcoholic Steatohepatitis Diagnostic by Type (2025-2032)
12.1.2 Global Nonalcoholic Steatohepatitis Diagnostic Market Size Forecast by Type (2025-2032)
12.1.3 Global Forecasted Price of Nonalcoholic Steatohepatitis Diagnostic by Type (2025-2032)
12.2 Global Nonalcoholic Steatohepatitis Diagnostic Market Forecast by Application (2025-2032)
12.2.1 Global Nonalcoholic Steatohepatitis Diagnostic Sales (K Units) Forecast by Application
12.2.2 Global Nonalcoholic Steatohepatitis Diagnostic Market Size (M USD) Forecast by Application (2025-2032)
13 Conclusion and Key Findings
LIST OF TABLES & FIGURES
List of Tables
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Nonalcoholic Steatohepatitis Diagnostic Market Size Comparison by Region (M USD)
Table 5. Global Nonalcoholic Steatohepatitis Diagnostic Sales (K Units) by Manufacturers (2019-2025)
Table 6. Global Nonalcoholic Steatohepatitis Diagnostic Sales Market Share by Manufacturers (2019-2025)
Table 7. Global Nonalcoholic Steatohepatitis Diagnostic Revenue (M USD) by Manufacturers (2019-2025)
Table 8. Global Nonalcoholic Steatohepatitis Diagnostic Revenue Share by Manufacturers (2019-2025)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Nonalcoholic Steatohepatitis Diagnostic as of 2022)
Table 10. Global Market Nonalcoholic Steatohepatitis Diagnostic Average Price (USD/Unit) of Key Manufacturers (2019-2025)
Table 11. Manufacturers Nonalcoholic Steatohepatitis Diagnostic Sales Sites and Area Served
Table 12. Manufacturers Nonalcoholic Steatohepatitis Diagnostic Product Type
Table 13. Global Nonalcoholic Steatohepatitis Diagnostic Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Industry Chain Map of Nonalcoholic Steatohepatitis Diagnostic
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Nonalcoholic Steatohepatitis Diagnostic Market Challenges
Table 22. Global Nonalcoholic Steatohepatitis Diagnostic Sales by Type (K Units)
Table 23. Global Nonalcoholic Steatohepatitis Diagnostic Market Size by Type (M USD)
Table 24. Global Nonalcoholic Steatohepatitis Diagnostic Sales (K Units) by Type (2019-2025)
Table 25. Global Nonalcoholic Steatohepatitis Diagnostic Sales Market Share by Type (2019-2025)
Table 26. Global Nonalcoholic Steatohepatitis Diagnostic Market Size (M USD) by Type (2019-2025)
Table 27. Global Nonalcoholic Steatohepatitis Diagnostic Market Size Share by Type (2019-2025)
Table 28. Global Nonalcoholic Steatohepatitis Diagnostic Price (USD/Unit) by Type (2019-2025)
Table 29. Global Nonalcoholic Steatohepatitis Diagnostic Sales (K Units) by Application
Table 30. Global Nonalcoholic Steatohepatitis Diagnostic Market Size by Application
Table 31. Global Nonalcoholic Steatohepatitis Diagnostic Sales by Application (2019-2025) & (K Units)
Table 32. Global Nonalcoholic Steatohepatitis Diagnostic Sales Market Share by Application (2019-2025)
Table 33. Global Nonalcoholic Steatohepatitis Diagnostic Sales by Application (2019-2025) & (M USD)
Table 34. Global Nonalcoholic Steatohepatitis Diagnostic Market Share by Application (2019-2025)
Table 35. Global Nonalcoholic Steatohepatitis Diagnostic Sales Growth Rate by Application (2019-2025)
Table 36. Global Nonalcoholic Steatohepatitis Diagnostic Sales by Region (2019-2025) & (K Units)
Table 37. Global Nonalcoholic Steatohepatitis Diagnostic Sales Market Share by Region (2019-2025)
Table 38. North America Nonalcoholic Steatohepatitis Diagnostic Sales by Country (2019-2025) & (K Units)
Table 39. Europe Nonalcoholic Steatohepatitis Diagnostic Sales by Country (2019-2025) & (K Units)
Table 40. Asia Pacific Nonalcoholic Steatohepatitis Diagnostic Sales by Region (2019-2025) & (K Units)
Table 41. South America Nonalcoholic Steatohepatitis Diagnostic Sales by Country (2019-2025) & (K Units)
Table 42. Middle East and Africa Nonalcoholic Steatohepatitis Diagnostic Sales by Region (2019-2025) & (K Units)
Table 43. Global Nonalcoholic Steatohepatitis Diagnostic Production (K Units) by Region (2019-2025)
Table 44. Global Nonalcoholic Steatohepatitis Diagnostic Revenue (US$ Million) by Region (2019-2025)
Table 45. Global Nonalcoholic Steatohepatitis Diagnostic Revenue Market Share by Region (2019-2025)
Table 46. Global Nonalcoholic Steatohepatitis Diagnostic Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2025)
Table 47. North America Nonalcoholic Steatohepatitis Diagnostic Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2025)
Table 48. Europe Nonalcoholic Steatohepatitis Diagnostic Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2025)
Table 49. Japan Nonalcoholic Steatohepatitis Diagnostic Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2025)
Table 50. China Nonalcoholic Steatohepatitis Diagnostic Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2025)
Table 51. Echosens Nonalcoholic Steatohepatitis Diagnostic Basic Information
Table 52. Echosens Nonalcoholic Steatohepatitis Diagnostic Product Overview
Table 53. Echosens Nonalcoholic Steatohepatitis Diagnostic Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2025)
Table 54. Echosens Business Overview
Table 55. Echosens Nonalcoholic Steatohepatitis Diagnostic SWOT Analysis
Table 56. Echosens Recent Developments
Table 57. Prometheus Laboratories Nonalcoholic Steatohepatitis Diagnostic Basic Information
Table 58. Prometheus Laboratories Nonalcoholic Steatohepatitis Diagnostic Product Overview
Table 59. Prometheus Laboratories Nonalcoholic Steatohepatitis Diagnostic Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2025)
Table 60. Prometheus Laboratories Business Overview
Table 61. Prometheus Laboratories Nonalcoholic Steatohepatitis Diagnostic SWOT Analysis
Table 62. Prometheus Laboratories Recent Developments
Table 63. GENFIT SA Nonalcoholic Steatohepatitis Diagnostic Basic Information
Table 64. GENFIT SA Nonalcoholic Steatohepatitis Diagnostic Product Overview
Table 65. GENFIT SA Nonalcoholic Steatohepatitis Diagnostic Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2025)
Table 66. GENFIT SA Nonalcoholic Steatohepatitis Diagnostic SWOT Analysis
Table 67. GENFIT SA Business Overview
Table 68. GENFIT SA Recent Developments
Table 69. Siemens Medical Solutions USA Nonalcoholic Steatohepatitis Diagnostic Basic Information
Table 70. Siemens Medical Solutions USA Nonalcoholic Steatohepatitis Diagnostic Product Overview
Table 71. Siemens Medical Solutions USA Nonalcoholic Steatohepatitis Diagnostic Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2025)
Table 72. Siemens Medical Solutions USA Business Overview
Table 73. Siemens Medical Solutions USA Recent Developments
Table 74. Inc. Nonalcoholic Steatohepatitis Diagnostic Basic Information
Table 75. Inc. Nonalcoholic Steatohepatitis Diagnostic Product Overview
Table 76. Inc. Nonalcoholic Steatohepatitis Diagnostic Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2025)
Table 77. Inc. Business Overview
Table 78. Inc. Recent Developments
Table 79. BioPredictive S.A.S Nonalcoholic Steatohepatitis Diagnostic Basic Information
Table 80. BioPredictive S.A.S Nonalcoholic Steatohepatitis Diagnostic Product Overview
Table 81. BioPredictive S.A.S Nonalcoholic Steatohepatitis Diagnostic Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2025)
Table 82. BioPredictive S.A.S Business Overview
Table 83. BioPredictive S.A.S Recent Developments
Table 84. Quest Diagnostics Incorporated. Nonalcoholic Steatohepatitis Diagnostic Basic Information
Table 85. Quest Diagnostics Incorporated. Nonalcoholic Steatohepatitis Diagnostic Product Overview
Table 86. Quest Diagnostics Incorporated. Nonalcoholic Steatohepatitis Diagnostic Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2025)
Table 87. Quest Diagnostics Incorporated. Business Overview
Table 88. Quest Diagnostics Incorporated. Recent Developments
Table 89. Meridian Bioscience Nonalcoholic Steatohepatitis Diagnostic Basic Information
Table 90. Meridian Bioscience Nonalcoholic Steatohepatitis Diagnostic Product Overview
Table 91. Meridian Bioscience Nonalcoholic Steatohepatitis Diagnostic Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2025)
Table 92. Meridian Bioscience Business Overview
Table 93. Meridian Bioscience Recent Developments
Table 94. Inc. Nonalcoholic Steatohepatitis Diagnostic Basic Information
Table 95. Inc. Nonalcoholic Steatohepatitis Diagnostic Product Overview
Table 96. Inc. Nonalcoholic Steatohepatitis Diagnostic Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2025)
Table 97. Inc. Business Overview
Table 98. Inc. Recent Developments
Table 99. Laboratory Corporation of America Holdings Nonalcoholic Steatohepatitis Diagnostic Basic Information
Table 100. Laboratory Corporation of America Holdings Nonalcoholic Steatohepatitis Diagnostic Product Overview
Table 101. Laboratory Corporation of America Holdings Nonalcoholic Steatohepatitis Diagnostic Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2025)
Table 102. Laboratory Corporation of America Holdings Business Overview
Table 103. Laboratory Corporation of America Holdings Recent Developments
Table 104. Global Nonalcoholic Steatohepatitis Diagnostic Sales Forecast by Region (2025-2032) & (K Units)
Table 105. Global Nonalcoholic Steatohepatitis Diagnostic Market Size Forecast by Region (2025-2032) & (M USD)
Table 106. North America Nonalcoholic Steatohepatitis Diagnostic Sales Forecast by Country (2025-2032) & (K Units)
Table 107. North America Nonalcoholic Steatohepatitis Diagnostic Market Size Forecast by Country (2025-2032) & (M USD)
Table 108. Europe Nonalcoholic Steatohepatitis Diagnostic Sales Forecast by Country (2025-2032) & (K Units)
Table 109. Europe Nonalcoholic Steatohepatitis Diagnostic Market Size Forecast by Country (2025-2032) & (M USD)
Table 110. Asia Pacific Nonalcoholic Steatohepatitis Diagnostic Sales Forecast by Region (2025-2032) & (K Units)
Table 111. Asia Pacific Nonalcoholic Steatohepatitis Diagnostic Market Size Forecast by Region (2025-2032) & (M USD)
Table 112. South America Nonalcoholic Steatohepatitis Diagnostic Sales Forecast by Country (2025-2032) & (K Units)
Table 113. South America Nonalcoholic Steatohepatitis Diagnostic Market Size Forecast by Country (2025-2032) & (M USD)
Table 114. Middle East and Africa Nonalcoholic Steatohepatitis Diagnostic Consumption Forecast by Country (2025-2032) & (Units)
Table 115. Middle East and Africa Nonalcoholic Steatohepatitis Diagnostic Market Size Forecast by Country (2025-2032) & (M USD)
Table 116. Global Nonalcoholic Steatohepatitis Diagnostic Sales Forecast by Type (2025-2032) & (K Units)
Table 117. Global Nonalcoholic Steatohepatitis Diagnostic Market Size Forecast by Type (2025-2032) & (M USD)
Table 118. Global Nonalcoholic Steatohepatitis Diagnostic Price Forecast by Type (2025-2032) & (USD/Unit)
Table 119. Global Nonalcoholic Steatohepatitis Diagnostic Sales (K Units) Forecast by Application (2025-2032)
Table 120. Global Nonalcoholic Steatohepatitis Diagnostic Market Size Forecast by Application (2025-2032) & (M USD)
List of Figures
Figure 1. Product Picture of Nonalcoholic Steatohepatitis Diagnostic
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Nonalcoholic Steatohepatitis Diagnostic Market Size (M USD), 2019-2032
Figure 5. Global Nonalcoholic Steatohepatitis Diagnostic Market Size (M USD) (2019-2032)
Figure 6. Global Nonalcoholic Steatohepatitis Diagnostic Sales (K Units) & (2019-2032)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Nonalcoholic Steatohepatitis Diagnostic Market Size by Country (M USD)
Figure 11. Nonalcoholic Steatohepatitis Diagnostic Sales Share by Manufacturers in 2023
Figure 12. Global Nonalcoholic Steatohepatitis Diagnostic Revenue Share by Manufacturers in 2023
Figure 13. Nonalcoholic Steatohepatitis Diagnostic Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2023
Figure 14. Global Market Nonalcoholic Steatohepatitis Diagnostic Average Price (USD/Unit) of Key Manufacturers in 2023
Figure 15. The Global 5 and 10 Largest Players: Market Share by Nonalcoholic Steatohepatitis Diagnostic Revenue in 2023
Figure 16. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 17. Global Nonalcoholic Steatohepatitis Diagnostic Market Share by Type
Figure 18. Sales Market Share of Nonalcoholic Steatohepatitis Diagnostic by Type (2019-2025)
Figure 19. Sales Market Share of Nonalcoholic Steatohepatitis Diagnostic by Type in 2023
Figure 20. Market Size Share of Nonalcoholic Steatohepatitis Diagnostic by Type (2019-2025)
Figure 21. Market Size Market Share of Nonalcoholic Steatohepatitis Diagnostic by Type in 2023
Figure 22. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 23. Global Nonalcoholic Steatohepatitis Diagnostic Market Share by Application
Figure 24. Global Nonalcoholic Steatohepatitis Diagnostic Sales Market Share by Application (2019-2025)
Figure 25. Global Nonalcoholic Steatohepatitis Diagnostic Sales Market Share by Application in 2023
Figure 26. Global Nonalcoholic Steatohepatitis Diagnostic Market Share by Application (2019-2025)
Figure 27. Global Nonalcoholic Steatohepatitis Diagnostic Market Share by Application in 2023
Figure 28. Global Nonalcoholic Steatohepatitis Diagnostic Sales Growth Rate by Application (2019-2025)
Figure 29. Global Nonalcoholic Steatohepatitis Diagnostic Sales Market Share by Region (2019-2025)
Figure 30. North America Nonalcoholic Steatohepatitis Diagnostic Sales and Growth Rate (2019-2025) & (K Units)
Figure 31. North America Nonalcoholic Steatohepatitis Diagnostic Sales Market Share by Country in 2023
Figure 32. U.S. Nonalcoholic Steatohepatitis Diagnostic Sales and Growth Rate (2019-2025) & (K Units)
Figure 33. Canada Nonalcoholic Steatohepatitis Diagnostic Sales (K Units) and Growth Rate (2019-2025)
Figure 34. Mexico Nonalcoholic Steatohepatitis Diagnostic Sales (Units) and Growth Rate (2019-2025)
Figure 35. Europe Nonalcoholic Steatohepatitis Diagnostic Sales and Growth Rate (2019-2025) & (K Units)
Figure 36. Europe Nonalcoholic Steatohepatitis Diagnostic Sales Market Share by Country in 2023
Figure 37. Germany Nonalcoholic Steatohepatitis Diagnostic Sales and Growth Rate (2019-2025) & (K Units)
Figure 38. France Nonalcoholic Steatohepatitis Diagnostic Sales and Growth Rate (2019-2025) & (K Units)
Figure 39. U.K. Nonalcoholic Steatohepatitis Diagnostic Sales and Growth Rate (2019-2025) & (K Units)
Figure 40. Italy Nonalcoholic Steatohepatitis Diagnostic Sales and Growth Rate (2019-2025) & (K Units)
Figure 41. Russia Nonalcoholic Steatohepatitis Diagnostic Sales and Growth Rate (2019-2025) & (K Units)
Figure 42. Asia Pacific Nonalcoholic Steatohepatitis Diagnostic Sales and Growth Rate (K Units)
Figure 43. Asia Pacific Nonalcoholic Steatohepatitis Diagnostic Sales Market Share by Region in 2023
Figure 44. China Nonalcoholic Steatohepatitis Diagnostic Sales and Growth Rate (2019-2025) & (K Units)
Figure 45. Japan Nonalcoholic Steatohepatitis Diagnostic Sales and Growth Rate (2019-2025) & (K Units)
Figure 46. South Korea Nonalcoholic Steatohepatitis Diagnostic Sales and Growth Rate (2019-2025) & (K Units)
Figure 47. India Nonalcoholic Steatohepatitis Diagnostic Sales and Growth Rate (2019-2025) & (K Units)
Figure 48. Southeast Asia Nonalcoholic Steatohepatitis Diagnostic Sales and Growth Rate (2019-2025) & (K Units)
Figure 49. South America Nonalcoholic Steatohepatitis Diagnostic Sales and Growth Rate (K Units)
Figure 50. South America Nonalcoholic Steatohepatitis Diagnostic Sales Market Share by Country in 2023
Figure 51. Brazil Nonalcoholic Steatohepatitis Diagnostic Sales and Growth Rate (2019-2025) & (K Units)
Figure 52. Argentina Nonalcoholic Steatohepatitis Diagnostic Sales and Growth Rate (2019-2025) & (K Units)
Figure 53. Columbia Nonalcoholic Steatohepatitis Diagnostic Sales and Growth Rate (2019-2025) & (K Units)
Figure 54. Middle East and Africa Nonalcoholic Steatohepatitis Diagnostic Sales and Growth Rate (K Units)
Figure 55. Middle East and Africa Nonalcoholic Steatohepatitis Diagnostic Sales Market Share by Region in 2023
Figure 56. Saudi Arabia Nonalcoholic Steatohepatitis Diagnostic Sales and Growth Rate (2019-2025) & (K Units)
Figure 57. UAE Nonalcoholic Steatohepatitis Diagnostic Sales and Growth Rate (2019-2025) & (K Units)
Figure 58. Egypt Nonalcoholic Steatohepatitis Diagnostic Sales and Growth Rate (2019-2025) & (K Units)
Figure 59. Nigeria Nonalcoholic Steatohepatitis Diagnostic Sales and Growth Rate (2019-2025) & (K Units)
Figure 60. South Africa Nonalcoholic Steatohepatitis Diagnostic Sales and Growth Rate (2019-2025) & (K Units)
Figure 61. Global Nonalcoholic Steatohepatitis Diagnostic Production Market Share by Region (2019-2025)
Figure 62. North America Nonalcoholic Steatohepatitis Diagnostic Production (K Units) Growth Rate (2019-2025)
Figure 63. Europe Nonalcoholic Steatohepatitis Diagnostic Production (K Units) Growth Rate (2019-2025)
Figure 64. Japan Nonalcoholic Steatohepatitis Diagnostic Production (K Units) Growth Rate (2019-2025)
Figure 65. China Nonalcoholic Steatohepatitis Diagnostic Production (K Units) Growth Rate (2019-2025)
Figure 66. Global Nonalcoholic Steatohepatitis Diagnostic Sales Forecast by Volume (2019-2032) & (K Units)
Figure 67. Global Nonalcoholic Steatohepatitis Diagnostic Market Size Forecast by Value (2019-2032) & (M USD)
Figure 68. Global Nonalcoholic Steatohepatitis Diagnostic Sales Market Share Forecast by Type (2025-2032)
Figure 69. Global Nonalcoholic Steatohepatitis Diagnostic Market Share Forecast by Type (2025-2032)
Figure 70. Global Nonalcoholic Steatohepatitis Diagnostic Sales Forecast by Application (2025-2032)
Figure 71. Global Nonalcoholic Steatohepatitis Diagnostic Market Share Forecast by Application (2025-2032)
